Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-18 Sale | 2024-03-20 5:00 pm | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER | 58,949 | $178.79 | $10,539,508 | 62,279 (Indirect Direct) | View |
| 2023-03-13 Sale | 2023-03-15 5:00 pm | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER | 53,125 | $152.28 | $8,089,998 | 62,279 (Indirect Direct) | View |
| 2022-03-24 Sale | 2022-03-25 5:09 pm | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Chief Commercial Officer | 27,690 | $159.2 | $4,408,375 | 62,279 (Indirect Direct) | View |
| 2022-03-01 Sale | 2022-03-01 6:08 pm | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Chief Commercial Officer | 21,488 | $148.25 | $3,185,599 | 62,279 (Indirect Direct) | View |
| 2021-12-15 Sale | 2021-12-17 5:01 pm | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Chief Commercial Officer | 2,152 | $128 | $275,456 | 48,442 (Indirect Direct) | View |
| 2021-03-01 Sale | 2021-03-02 8:26 pm | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan SVP, US Commercial Operations | 13,773 | $108.59 | $1,495,576 | 52,307 (Indirect Direct) | View |
| 2020-12-29 Sale | 2020-12-31 1:15 pm | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Commercial Operations | 25,290 | $105 | $2,655,450 | 52,307 (Indirect Direct) | View |
| 2020-05-12 Sale | 2020-05-12 5:44 pm | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan SVP, US Commercial Operations | 23,024 | $90 | $2,072,211 | 54,098 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-18 Exercise | 2024-03-20 5:00 pm | 2018-02-16 2027-02-15 | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER | 26,110 | $61.36 | 62,279 (Direct) | View |
| 2024-02-28 Tax Withholding | 2024-03-01 5:50 pm | N/A N/A | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER | 26,121 | $178.99 | 95,118 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:15 pm | 2025-02-15 2034-02-14 | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER | 98,045 | $0 | 160,324 (Direct) | View |
| 2023-03-13 Exercise | 2023-03-15 5:00 pm | 2017-02-18 2026-02-17 | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER | 21,810 | $54.86 | 62,279 (Direct) | View |
| 2023-02-28 Tax Withholding | 2023-03-02 5:02 pm | N/A N/A | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, COMMERCIAL OPERATIONS | 24,910 | $154.28 | 93,594 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 6:02 pm | 2024-02-16 2033-02-15 | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, COMMERCIAL OPERATIONS | 91,336 | $0 | 153,615 (Direct) | View |
| 2022-03-24 Exercise | 2022-03-25 5:09 pm | 2016-02-19 2025-02-18 | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Chief Commercial Officer | 27,690 | $58.88 | 62,279 (Direct) | View |
| 2022-02-25 Tax Withholding | 2022-03-01 6:08 pm | N/A N/A | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Chief Commercial Officer | 17,093 | $149.54 | 62,279 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:42 pm | 2023-02-17 2032-02-16 | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Chief Commercial Officer | 89,633 | $0 | 138,075 (Direct) | View |
| 2021-12-10 Tax Withholding | 2021-12-14 5:00 pm | N/A N/A | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Chief Commercial Officer | 1,713 | $124.15 | 50,594 (Direct) | View |
| 2021-02-28 Tax Withholding | 2021-03-02 8:26 pm | N/A N/A | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan SVP, US Commercial Operations | 10,957 | $107.74 | 52,307 (Direct) | View |
| 2021-02-18 Option Award | 2021-02-22 6:19 pm | 2022-02-18 2031-02-17 | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan SVP, US Commercial Operations | 68,208 | $0 | 120,515 (Direct) | View |
| 2020-12-29 Exercise | 2020-12-31 1:15 pm | N/A N/A | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Commercial Operations | 25,290 | $51.42 | 52,307 (Direct) | View |
| 2020-12-29 Exercise | 2020-12-31 1:15 pm | 2015-02-20 2024-02-19 | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Commercial Operations | 25,290 | $0 | 52,307 (Direct) | View |
| 2020-12-10 Tax Withholding | 2020-12-11 4:31 pm | N/A N/A | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan SVP, US Commercial Operations | 1,791 | $108.67 | 52,307 (Direct) | View |
| 2020-02-28 Tax Withholding | 2020-03-03 4:57 pm | N/A N/A | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan SVP, US Commercial Operations | 9,703 | $85.42 | 77,122 (Direct) | View |
| 2020-02-20 Option Award | 2020-02-24 5:59 pm | 2021-02-20 2030-02-19 | AbbVie Inc. | ABBV | Stewart Jeffrey Ryan SVP, US Commercial Operations | 70,995 | $0 | 135,924 (Direct) | View |